- ASCO 2019 - Melanoma: The advantages of targeted dual therapy confirmed at five years
Press release - 4th June 2019 - ASCO 2019 - Urothelial cancer (bladder and urinary tract) - New evidence of the value of immunotherapy
Press release, 3 june 2019 - ASCO 2019 - Paediatric cancers: Larotrectinib, first targeted therapy for childhood solid tumours, shown to be effective
Press release, 3 june 2019 - ASCO 2019 - Artificial intelligence can predict the chances of post-treatment fatigue in breast cancer.
Press release, 1st june 2019 - ASCO 2019 - Prostate cancer: Darolutamide reduces the risk of pain and does not worsen the quality of life in patients treated for prostate cancer
Press release, 31st may 2019
Catégorie de la page:
